Literature DB >> 21440298

Stem cell marker nestin is expressed in plasma cells of multiple myeloma patients.

H Svachova1, L Pour, J Sana, L Kovarova, K R Muthu Raja, R Hajek.   

Abstract

Nestin is considered to be a characteristic marker of multipotent proliferative precursors found in some embryonic and fetal tissues. Its expression might be a suitable diagnostic and prognostic indicator of malignancy and a potential marker of cancer stem cells in solid tumors. Unexpectedly, nestin protein was detected in mature CD138(+)CD38(+) plasma cells of multiple myeloma patients and statistical analysis confirmed significant differences between myeloma patients and control group without hematological malignancy. Our results represent the first evidence of nestin expression in multiple myeloma. Further studies are required to elucidate the role of this protein in multiple myeloma.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21440298     DOI: 10.1016/j.leukres.2011.03.001

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  6 in total

Review 1.  Can we change the disease biology of multiple myeloma?

Authors:  Ivan Borrello
Journal:  Leuk Res       Date:  2012-11       Impact factor: 3.156

2.  Necessity of flow cytometry assessment of circulating plasma cells and its connection with clinical characteristics of primary and secondary plasma cell leukaemia.

Authors:  Renata Bezdekova; Tomas Jelinek; Romana Kralova; Martin Stork; Petra Polackova; Pavla Vsianska; Lucie Brozova; Jiri Jarkovsky; Martina Almasi; Ivanna Boichuk; Zdenka Knechtova; Miroslav Penka; Ludek Pour; Sabina Sevcikova; Roman Hajek; Lucie Rihova
Journal:  Br J Haematol       Date:  2021-09-09       Impact factor: 8.615

Review 3.  Nestin as a marker of cancer stem cells.

Authors:  Jakub Neradil; Renata Veselska
Journal:  Cancer Sci       Date:  2015-05-26       Impact factor: 6.716

4.  Expression of HSV-1 receptors in EBV-associated lymphoproliferative disease determines susceptibility to oncolytic HSV.

Authors:  P-Y Wang; M A Currier; L Hansford; D Kaplan; E A Chiocca; H Uchida; W F Goins; J B Cohen; J C Glorioso; T H van Kuppevelt; X Mo; T P Cripe
Journal:  Gene Ther       Date:  2012-12-20       Impact factor: 5.250

Review 5.  Cancer Stem Cells: The Potential Targets of Chinese Medicines and Their Active Compounds.

Authors:  Ming Hong; Hor Yue Tan; Sha Li; Fan Cheung; Ning Wang; Tadashi Nagamatsu; Yibin Feng
Journal:  Int J Mol Sci       Date:  2016-06-07       Impact factor: 5.923

6.  CD138- multiple myeloma cells express high level of CHK1 which correlated to overall survival in MM patient.

Authors:  Dong Wu; Peihua Zhang; Fangmei Li; Ying Shen; Hongli Chen; Yuandong Feng; Aili He; Fangxia Wang
Journal:  Aging (Albany NY)       Date:  2020-11-10       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.